Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model

Boissier, 1960, A simple novel method to explore tranquilizer activity: the chimney test (in French), Med Exp (Basel), 3, 81, 10.1159/000134913

Cadart, 2002, Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats, Pharm Res, 19, 209, 10.1023/A:1014233102342

Kamiński, 2008, Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)-3-substituted pyrrolidine-2,5-dione derivatives, Acta Pol Pharm Drug Res, 65, 457

Lange, 1977, Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity, Pharmazie, 32, 82

Litchfield, 1949, A simplified method of evaluating dose-effect experiments, J Pharmacol Exp Ther, 96, 99

Löscher, 1991, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res, 8, 79, 10.1016/0920-1211(91)90075-Q

Löscher, 2000, The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures, Epilepsy Res, 38, 231, 10.1016/S0920-1211(99)00095-9

Łuszczki, 2009, Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model, Eur J Pharmacol, 602, 298, 10.1016/j.ejphar.2008.11.049

Łuszczki, 2008, Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model, J Neural Transm, 115, 1485, 10.1007/s00702-008-0046-3

Łuszczki, 2009, N-(anilinomethyl)-p-isopropoxyphenyl-succinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model, Neurosci Res, 64, 267, 10.1016/j.neures.2009.03.010

Łuszczki, 2006, Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model, Naunyn-Schmiedeberg’s Arch Pharmacol, 373, 169, 10.1007/s00210-006-0055-4

Łuszczki, 2007, Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model, Epilepsy Res, 76, 66, 10.1016/j.eplepsyres.2007.06.010

Łuszczki, 2003, Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice, Pharmacol Biochem Behav, 75, 319, 10.1016/S0091-3057(03)00081-9

Łuszczki, 2005, Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis, Neuropsychopharmacology, 30, 958, 10.1038/sj.npp.1300602

Meyer, 1979, A method for the routine assessment of fore- and hindlimb grip strength of rats and mice, Neurobehav Toxicol, 1, 233

Stables, 1997, Chapter 16 – The NIH Anti-convulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project, 191

Venault, 1986, Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks, Nature, 321, 864, 10.1038/321864a0

White, 2002, Discovery and preclinical development of antiepileptic drugs, 36

Zejc, 1990, Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides, Pol J Pharmacol Pharm, 42, 69